Serum miR-3620-3p as a Novel Biomarker for Ankylosing Spondylitis

OBJECTIVE: Using microRNA (miR) as a biomarker has been a new way for diagnosing many diseases Although many studies on miR-biomarker have been published, researches on miR-biomarker in ankylosing spondylitis (AS) are limited Therefore, the objective of this study was to valiate a candidate serum mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hae-in, Park, Ki-jeong, Kim, Hui-Ju, Choi, Ah-Ra, Jin, So-Hee, Kim, Tae-Jong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Rheumatology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324918/
https://www.ncbi.nlm.nih.gov/pubmed/37476698
http://dx.doi.org/10.4078/jrd.2022.29.1.33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324918/
https://www.ncbi.nlm.nih.gov/pubmed/37476698
http://dx.doi.org/10.4078/jrd.2022.29.1.33

Ejemplares similares